US court rules to protect generic drug makers

June 24, 2013

Manufacturers of generic drugs cannot be sued for adverse side effects caused by products that they did not themselves design, the US Supreme Court ruled on Monday.

In a five-to-four decision, the justices found in favor of Mutual Pharmaceutical, overturning a $21 million award against it after a woman suffered horrific burns after taking an anti-inflammatory in 2004.

are copies of drugs already developed by other firms and approved by , and Mutual argued that any faults in the product are thus not its responsibility.

In his written opinion, conservative Justice Samuel Alito said the court had reached its finding "reluctantly", noting the "tragic" circumstances of the case which had left the victim "severely disfigured" and "nearly blind."

But he ruled it was impossible for manufacturers "to comply with both state and federal law, New Hampshire's warning-based design-defect cause of action is pre-empted with respect to FDA-approved drugs sold in interstate commerce."

" are also prohibited from making any unilateral changes to a drug label," it added.

In the case before the court, plaintiff Karen Bartlett suffered and pain and several months in a coma after using an anti-inflammatory to treat a sore shoulder.

Explore further: Supreme Court ruling supports generic drug makers

Related Stories

Supreme Court ruling supports generic drug makers

April 18, 2012

The US Supreme Court ruled Tuesday that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions.

Court: Can generic makers be sued for drug flaws?

November 30, 2012

(AP)—The Supreme Court will decide whether generic drug manufacturers can be held responsible in state courts for possible design defects that are in the brand-name medicine they are copying.

High court weighs drug companies' generics policy

March 25, 2013

(AP)—The Supreme Court is struggling with whether it should stop pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs.

US: 'Pay to delay' generic drugs can be illegal (Update)

June 17, 2013

The Supreme Court ruled Monday that deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can be sometimes be illegal and ...

Recommended for you

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.